S&P Dow Jones Indices announced that the vaccine maker and pharmaceutical company is replacing Alexion Pharmaceuticals (ALXN) - Get Alexion Pharmaceuticals, Inc. Report on that day. AstraZeneca (AZN) - Get Astrazeneca PLC Sponsored ADR Report is acquiring Alexion Pharmaceuticals in a $39 billion takeover deal.
Investors are excited about Moderna's latest news, which is reflected in its stock price as the stock opened more than 6% higher to $275.79 Friday. Moderna shares have surged over 215% in the past year.
The company also posted a strong first quarter this year, with revenue rising to $1.9 billion.
Moderna is expected to deliver up to 1 billion doses of its coronavirus vaccine this year.